298 related articles for article (PubMed ID: 15183902)
1. Haploidentical transplantation for acute lymphoblastic leukemia in childhood.
Klingebiel T; Handgretinger R; Lang P; Bader P; Niethammer D
Blood Rev; 2004 Sep; 18(3):181-92. PubMed ID: 15183902
[TBL] [Abstract][Full Text] [Related]
2. Megadose transplantation of purified peripheral blood CD34(+) progenitor cells from HLA-mismatched parental donors in children.
Handgretinger R; Klingebiel T; Lang P; Schumm M; Neu S; Geiselhart A; Bader P; Schlegel PG; Greil J; Stachel D; Herzog RJ; Niethammer D
Bone Marrow Transplant; 2001 Apr; 27(8):777-83. PubMed ID: 11477433
[TBL] [Abstract][Full Text] [Related]
3. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype.
Aversa F; Tabilio A; Velardi A; Cunningham I; Terenzi A; Falzetti F; Ruggeri L; Barbabietola G; Aristei C; Latini P; Reisner Y; Martelli MF
N Engl J Med; 1998 Oct; 339(17):1186-93. PubMed ID: 9780338
[TBL] [Abstract][Full Text] [Related]
4. Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning.
Ogawa H; Ikegame K; Yoshihara S; Kawakami M; Fujioka T; Masuda T; Taniguchi Y; Hasei H; Kaida K; Inoue T; Kim EH; Kawase I
Biol Blood Marrow Transplant; 2006 Oct; 12(10):1073-84. PubMed ID: 17084371
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome after haploidentical stem cell transplantation in children.
Lang P; Greil J; Bader P; Handgretinger R; Klingebiel T; Schumm M; Schlegel PG; Feuchtinger T; Pfeiffer M; Scheel-Walter H; Führer M; Martin D; Niethammer D
Blood Cells Mol Dis; 2004; 33(3):281-7. PubMed ID: 15528145
[TBL] [Abstract][Full Text] [Related]
6. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
[TBL] [Abstract][Full Text] [Related]
7. Graft manipulation and reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation from mismatched unrelated and mismatched/haploidentical related donors in pediatric leukemia patients.
Gonzalez-Vicent M; Perez A; Abad L; Sevilla J; Ramirez M; Diaz MA
J Pediatr Hematol Oncol; 2010 Apr; 32(3):e85-90. PubMed ID: 20216238
[TBL] [Abstract][Full Text] [Related]
8. A modified haploidentical nonmyeloablative transplantation without T cell depletion for high-risk acute leukemia: successful engraftment and mild GVHD.
Guo M; Sun Z; Sun QY; Han Q; Yu CL; Wang DH; Qiao JH; Chen B; Sun WJ; Hu KX; Liu GX; Liu B; Zhao RC; Ai H
Biol Blood Marrow Transplant; 2009 Aug; 15(8):930-7. PubMed ID: 19589482
[TBL] [Abstract][Full Text] [Related]
9. Mismatched T cell-depleted hematopoietic stem cell transplantation for children with high-risk acute leukemia.
Aversa F; Terenzi A; Felicini R; Tabilio A; Falzetti F; Carotti A; Falcinelli F; Sodani P; Amici A; Zucchetti P; Mazzarino I; Martelli MF
Bone Marrow Transplant; 1998 Dec; 22 Suppl 5():S29-32. PubMed ID: 9989886
[TBL] [Abstract][Full Text] [Related]
10. Hematopoietic stem cell transplantation in children with hematological malignancies across HLA barriers--reasonable alternative?
Sedlácek P; Starý J; Vodváková S; Poloucková A; Gasová Z; Marinov I; Formánková R
Neoplasma; 2001; 48(4):302-6. PubMed ID: 11712683
[TBL] [Abstract][Full Text] [Related]
11. Rapid and effective CD3 T-cell depletion with a magnetic cell sorting program to produce peripheral blood progenitor cell products for haploidentical transplantation in children and adults.
Dykes JH; Toporski J; Juliusson G; Békássy AN; Lenhoff S; Lindmark A; Scheding S
Transfusion; 2007 Nov; 47(11):2134-42. PubMed ID: 17958543
[TBL] [Abstract][Full Text] [Related]
12. Selected CD34 blood cell allografts for older patients: low transplant-related mortality, graft failure and acute GvHD.
Roberts MM; Dyson P; Rawling C; Thorp D; Rawling T; White D; Horvath N; Bardy P; Hui CH; Dart GW; To LB; Hughes TP
Cytotherapy; 2003; 5(6):534-41. PubMed ID: 14660049
[TBL] [Abstract][Full Text] [Related]
13. [Application of FBC conditioning regimen in HLA haplotype peripheral blood stem cell transplantation].
Wu B; Guo K; Song Z; Yan D; Yang Y; Xiao L
Zhonghua Xue Ye Xue Za Zhi; 2002 Apr; 23(4):194-7. PubMed ID: 12133456
[TBL] [Abstract][Full Text] [Related]
14. Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: an update.
Bethge WA; Faul C; Bornhäuser M; Stuhler G; Beelen DW; Lang P; Stelljes M; Vogel W; Hägele M; Handgretinger R; Kanz L
Blood Cells Mol Dis; 2008; 40(1):13-9. PubMed ID: 17869547
[TBL] [Abstract][Full Text] [Related]
15. Unrelated donor or partially matched related donor peripheral stem cell transplant with CD34+ selection and CD3+ addback for pediatric patients with leukemias.
Bunin N; Aplenc R; Grupp S; Pierson G; Monos D
Bone Marrow Transplant; 2006 Jan; 37(2):143-9. PubMed ID: 16284615
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of donor lymphocyte infusions following mismatched stem cell transplantation.
Or R; Hadar E; Bitan M; Resnick IB; Aker M; Ackerstein A; Samuel S; Tsirigotis P; Gesundheit B; Slavin S; Shapira MY
Biol Blood Marrow Transplant; 2006 Dec; 12(12):1295-301. PubMed ID: 17162211
[TBL] [Abstract][Full Text] [Related]
17. [Transplantation of highly purified CD34+ hematologic peripheral stem cells from haploidentical related donors in the treatment of children with non-malignant diseases].
Starý J; Sedlácek P; Vodvárková S; Poloucková A; Formánková R; Gasová Z; Marinov I
Cas Lek Cesk; 2002 Mar; 141(6):176-81. PubMed ID: 11977835
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic peripheral stem cell transplantation using positively selected CD34+ cells from HLA-mismatched donors.
Matsuda Y; Hara J; Osugi Y; Fujisaki H; Takai K; Ohta H; Nakanishi K; Tokimasa S; Miyoshi H; Tanaka-Taya K; Yamanishi K; Okada S
Bone Marrow Transplant; 1998 Feb; 21(4):355-60. PubMed ID: 9509968
[TBL] [Abstract][Full Text] [Related]
19. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
Strober S
Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic cell transplantation from an HLA-mismatched familial donor is feasible without ex vivo-T cell depletion after reduced-intensity conditioning with busulfan, fludarabine, and antithymocyte globulin.
Lee KH; Lee JH; Lee JH; Kim DY; Kim SH; Shin HJ; Lee YS; Kang YA; Seol M; Ryu SG
Biol Blood Marrow Transplant; 2009 Jan; 15(1):61-72. PubMed ID: 19135944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]